List of bibliographic references indexed by Levodopa (pharmacology)
Number of relevant bibliographic references: 45.
[0-20] [
0 - 20][
0 - 45][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000464 (2016) |
Lucia Ricciardi [Royaume-Uni] ; Francesco Bove [Italie] ; Kristy J. Espay [États-Unis] ; Francesco Lena [Italie] ; Nicola Modugno [Italie] ; Yu-Yan Poon [Canada] ; Robert Krikorian [États-Unis] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Canada] | 24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease. |
000474 (2015) |
Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada] | What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease? |
000522 (2015) |
Tom M. Johnston [Canada] ; Susan H. Fox | Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates. |
000580 (2015) |
Laurent Grégoire [Canada] ; Tara Smith [Canada] ; Vijitha Senanayake [Canada] ; Asuka Mochizuki [Japon] ; Edith Miville-Godbout [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. |
000752 (2015) |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie] | Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion. |
000786 (2015) |
Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications. |
000877 (2014) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. |
000904 (2014) |
Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | The effects of dopaminergic medication on dynamic decision making in Parkinson's disease. |
000A35 (2014) |
St Masoud [Canada] ; Lm Vecchio [Canada] ; Y. Bergeron ; Mm Hossain [États-Unis] ; Lt Nguyen [Canada] ; Mk Bermejo [Canada] ; B. Kile [États-Unis] ; Td Sotnikova [Italie, Russie] ; Wb Siesser [États-Unis] ; Rr Gainetdinov [Italie, Russie] ; Rm Wightman [États-Unis] ; Mg Caron [États-Unis] ; Jr Richardson [États-Unis] ; Gw Miller [États-Unis] ; Aj Ramsey [Canada] ; M. Cyr ; A. Salahpour [Canada] | Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits |
000B38 (2014) |
Kristina Martinu [Canada] ; Atsuko Nagano-Saito [Canada] ; Stuart Fogel [Canada] ; Oury Monchi [Canada] | Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD |
000C92 (2013) |
Vincent A. Jourdain [Canada] ; Laurent Grégoire ; Marc Morissette ; Nicolas Morin ; Martin Parent ; Thérèse Di Paolo | Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy. |
000E13 (2013) |
Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan ; Martin J. Mckeown ; Silke Appel-Cresswell ; A Jon Stoessl ; Jason J S. Barton | Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude. |
001123 (2012) |
Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr | Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model. |
001191 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie | L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
001406 (2012) |
K. Martinu [Canada] ; C. Degroot [Canada] ; C. Madjar [Canada] ; A. P. Strafella [Canada] ; O. Monchi [Canada] | Levodopa influences striatal activity but does not affect cortical hyper‐activity in Parkinson’s disease |
001473 (2012) |
Alain Dagher [Canada] | ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE |
001538 (2012) |
Aimee J. Nelson [Canada] ; Azra Premji [Canada] ; Navjot Rai [Canada] ; Tasnuva Hoque [Canada] ; Mark Tommerdahl [États-Unis] ; Robert Chen [Canada] | Dopamine Alters Tactile Perception in Parkinson's Disease |
001601 (2011) |
James K R. Stevenson [Canada] ; Meeko M K. Oishi ; Sara Farajian ; Edmond Cretu ; Edna Ty ; Martin J. Mckeown | Response to sensory uncertainty in Parkinson's disease: a marker of cerebellar dysfunction? |
001680 (2011) |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
001A25 (2010) |
Wing-Lok Au [Singapour] ; Ni Lei ; Meeko M K. Oishi ; Martin J. Mckeown | L-dopa induces under-damped visually guided motor responses in Parkinson's disease. |
001A57 (2010) |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di Paolo | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Levodopa (pharmacology)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Levodopa (pharmacology)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Levodopa (pharmacology)
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |